nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP3A4—Topotecan—ovarian cancer	0.0329	0.354	CbGbCtD
Esomeprazole—CYP3A4—Vinorelbine—ovarian cancer	0.0232	0.249	CbGbCtD
Esomeprazole—CYP3A4—Paclitaxel—ovarian cancer	0.0163	0.175	CbGbCtD
Esomeprazole—CYP3A4—Docetaxel—ovarian cancer	0.0118	0.127	CbGbCtD
Esomeprazole—CYP3A4—Doxorubicin—ovarian cancer	0.00877	0.0945	CbGbCtD
Esomeprazole—Omeprazole—CYP1B1—ovarian cancer	0.00709	0.355	CrCbGaD
Esomeprazole—Lansoprazole—CYP1B1—ovarian cancer	0.00648	0.325	CrCbGaD
Esomeprazole—Pantoprazole—ABCB1—ovarian cancer	0.00249	0.125	CrCbGaD
Esomeprazole—Omeprazole—ABCB1—ovarian cancer	0.00203	0.102	CrCbGaD
Esomeprazole—Lansoprazole—ABCB1—ovarian cancer	0.00186	0.0932	CrCbGaD
Esomeprazole—Chest pain—Docetaxel—ovarian cancer	0.000477	0.000538	CcSEcCtD
Esomeprazole—Myalgia—Docetaxel—ovarian cancer	0.000477	0.000538	CcSEcCtD
Esomeprazole—Arthralgia—Docetaxel—ovarian cancer	0.000477	0.000538	CcSEcCtD
Esomeprazole—Pancytopenia—Doxorubicin—ovarian cancer	0.000477	0.000537	CcSEcCtD
Esomeprazole—Nausea—Vinorelbine—ovarian cancer	0.000476	0.000537	CcSEcCtD
Esomeprazole—Renal failure—Epirubicin—ovarian cancer	0.000475	0.000536	CcSEcCtD
Esomeprazole—Dyspepsia—Paclitaxel—ovarian cancer	0.000475	0.000535	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000474	0.000534	CcSEcCtD
Esomeprazole—Jaundice—Epirubicin—ovarian cancer	0.000471	0.000531	CcSEcCtD
Esomeprazole—Stomatitis—Epirubicin—ovarian cancer	0.000471	0.000531	CcSEcCtD
Esomeprazole—Conjunctivitis—Epirubicin—ovarian cancer	0.00047	0.00053	CcSEcCtD
Esomeprazole—Urinary tract infection—Epirubicin—ovarian cancer	0.00047	0.00053	CcSEcCtD
Esomeprazole—Neutropenia—Doxorubicin—ovarian cancer	0.000469	0.000529	CcSEcCtD
Esomeprazole—Dysuria—Doxorubicin—ovarian cancer	0.000469	0.000529	CcSEcCtD
Esomeprazole—Decreased appetite—Paclitaxel—ovarian cancer	0.000469	0.000529	CcSEcCtD
Esomeprazole—Dry mouth—Docetaxel—ovarian cancer	0.000467	0.000526	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000466	0.000526	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000466	0.000525	CcSEcCtD
Esomeprazole—Fatigue—Paclitaxel—ovarian cancer	0.000465	0.000524	CcSEcCtD
Esomeprazole—Pollakiuria—Doxorubicin—ovarian cancer	0.000464	0.000523	CcSEcCtD
Esomeprazole—Constipation—Paclitaxel—ovarian cancer	0.000461	0.00052	CcSEcCtD
Esomeprazole—Pain—Paclitaxel—ovarian cancer	0.000461	0.00052	CcSEcCtD
Esomeprazole—Haematuria—Epirubicin—ovarian cancer	0.000461	0.00052	CcSEcCtD
Esomeprazole—Confusional state—Docetaxel—ovarian cancer	0.000461	0.00052	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000458	0.000516	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000457	0.000516	CcSEcCtD
Esomeprazole—Anaphylactic shock—Docetaxel—ovarian cancer	0.000457	0.000515	CcSEcCtD
Esomeprazole—Weight increased—Doxorubicin—ovarian cancer	0.000457	0.000515	CcSEcCtD
Esomeprazole—Epistaxis—Epirubicin—ovarian cancer	0.000456	0.000514	CcSEcCtD
Esomeprazole—Infection—Docetaxel—ovarian cancer	0.000454	0.000512	CcSEcCtD
Esomeprazole—Weight decreased—Doxorubicin—ovarian cancer	0.000454	0.000512	CcSEcCtD
Esomeprazole—Sinusitis—Epirubicin—ovarian cancer	0.000454	0.000511	CcSEcCtD
Esomeprazole—Agranulocytosis—Epirubicin—ovarian cancer	0.000451	0.000509	CcSEcCtD
Esomeprazole—Shock—Docetaxel—ovarian cancer	0.00045	0.000507	CcSEcCtD
Esomeprazole—Nervous system disorder—Docetaxel—ovarian cancer	0.000449	0.000506	CcSEcCtD
Esomeprazole—Thrombocytopenia—Docetaxel—ovarian cancer	0.000448	0.000505	CcSEcCtD
Esomeprazole—Infestation NOS—Doxorubicin—ovarian cancer	0.000448	0.000504	CcSEcCtD
Esomeprazole—Infestation—Doxorubicin—ovarian cancer	0.000448	0.000504	CcSEcCtD
Esomeprazole—Tachycardia—Docetaxel—ovarian cancer	0.000446	0.000503	CcSEcCtD
Esomeprazole—Feeling abnormal—Paclitaxel—ovarian cancer	0.000445	0.000501	CcSEcCtD
Esomeprazole—Skin disorder—Docetaxel—ovarian cancer	0.000444	0.000501	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000444	0.0005	CcSEcCtD
Esomeprazole—Bradycardia—Epirubicin—ovarian cancer	0.000442	0.000498	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000441	0.000497	CcSEcCtD
Esomeprazole—Renal failure—Doxorubicin—ovarian cancer	0.00044	0.000496	CcSEcCtD
Esomeprazole—Stomatitis—Doxorubicin—ovarian cancer	0.000436	0.000492	CcSEcCtD
Esomeprazole—Jaundice—Doxorubicin—ovarian cancer	0.000436	0.000492	CcSEcCtD
Esomeprazole—Anorexia—Docetaxel—ovarian cancer	0.000436	0.000491	CcSEcCtD
Esomeprazole—Rhinitis—Epirubicin—ovarian cancer	0.000435	0.000491	CcSEcCtD
Esomeprazole—Conjunctivitis—Doxorubicin—ovarian cancer	0.000435	0.00049	CcSEcCtD
Esomeprazole—Urinary tract infection—Doxorubicin—ovarian cancer	0.000435	0.00049	CcSEcCtD
Esomeprazole—Hepatitis—Epirubicin—ovarian cancer	0.000434	0.000489	CcSEcCtD
Esomeprazole—Hypoaesthesia—Epirubicin—ovarian cancer	0.000432	0.000487	CcSEcCtD
Esomeprazole—Pharyngitis—Epirubicin—ovarian cancer	0.000431	0.000486	CcSEcCtD
Esomeprazole—Urinary tract disorder—Epirubicin—ovarian cancer	0.000429	0.000483	CcSEcCtD
Esomeprazole—Urticaria—Paclitaxel—ovarian cancer	0.000429	0.000483	CcSEcCtD
Esomeprazole—Oedema peripheral—Epirubicin—ovarian cancer	0.000428	0.000482	CcSEcCtD
Esomeprazole—Haematuria—Doxorubicin—ovarian cancer	0.000427	0.000481	CcSEcCtD
Esomeprazole—Connective tissue disorder—Epirubicin—ovarian cancer	0.000427	0.000481	CcSEcCtD
Esomeprazole—Abdominal pain—Paclitaxel—ovarian cancer	0.000427	0.000481	CcSEcCtD
Esomeprazole—Body temperature increased—Paclitaxel—ovarian cancer	0.000427	0.000481	CcSEcCtD
Esomeprazole—Urethral disorder—Epirubicin—ovarian cancer	0.000426	0.00048	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000423	0.000477	CcSEcCtD
Esomeprazole—Epistaxis—Doxorubicin—ovarian cancer	0.000422	0.000476	CcSEcCtD
Esomeprazole—Sinusitis—Doxorubicin—ovarian cancer	0.00042	0.000473	CcSEcCtD
Esomeprazole—Visual impairment—Epirubicin—ovarian cancer	0.000418	0.000472	CcSEcCtD
Esomeprazole—Agranulocytosis—Doxorubicin—ovarian cancer	0.000418	0.000471	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000417	0.00047	CcSEcCtD
Esomeprazole—Insomnia—Docetaxel—ovarian cancer	0.000414	0.000466	CcSEcCtD
Esomeprazole—Paraesthesia—Docetaxel—ovarian cancer	0.000411	0.000463	CcSEcCtD
Esomeprazole—Erythema multiforme—Epirubicin—ovarian cancer	0.000411	0.000463	CcSEcCtD
Esomeprazole—Bradycardia—Doxorubicin—ovarian cancer	0.000409	0.000461	CcSEcCtD
Esomeprazole—Dyspnoea—Docetaxel—ovarian cancer	0.000408	0.00046	CcSEcCtD
Esomeprazole—Somnolence—Docetaxel—ovarian cancer	0.000407	0.000458	CcSEcCtD
Esomeprazole—Eye disorder—Epirubicin—ovarian cancer	0.000406	0.000457	CcSEcCtD
Esomeprazole—Tinnitus—Epirubicin—ovarian cancer	0.000405	0.000456	CcSEcCtD
Esomeprazole—Flushing—Epirubicin—ovarian cancer	0.000403	0.000454	CcSEcCtD
Esomeprazole—Rhinitis—Doxorubicin—ovarian cancer	0.000403	0.000454	CcSEcCtD
Esomeprazole—Dyspepsia—Docetaxel—ovarian cancer	0.000403	0.000454	CcSEcCtD
Esomeprazole—Hepatitis—Doxorubicin—ovarian cancer	0.000402	0.000453	CcSEcCtD
Esomeprazole—Hypoaesthesia—Doxorubicin—ovarian cancer	0.0004	0.000451	CcSEcCtD
Esomeprazole—Pharyngitis—Doxorubicin—ovarian cancer	0.000399	0.000449	CcSEcCtD
Esomeprazole—Decreased appetite—Docetaxel—ovarian cancer	0.000398	0.000448	CcSEcCtD
Esomeprazole—Hypersensitivity—Paclitaxel—ovarian cancer	0.000398	0.000448	CcSEcCtD
Esomeprazole—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000397	0.000447	CcSEcCtD
Esomeprazole—Oedema peripheral—Doxorubicin—ovarian cancer	0.000396	0.000446	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000395	0.000445	CcSEcCtD
Esomeprazole—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000395	0.000445	CcSEcCtD
Esomeprazole—Fatigue—Docetaxel—ovarian cancer	0.000394	0.000444	CcSEcCtD
Esomeprazole—Urethral disorder—Doxorubicin—ovarian cancer	0.000394	0.000444	CcSEcCtD
Esomeprazole—Immune system disorder—Epirubicin—ovarian cancer	0.000392	0.000442	CcSEcCtD
Esomeprazole—Mediastinal disorder—Epirubicin—ovarian cancer	0.000391	0.000441	CcSEcCtD
Esomeprazole—Pain—Docetaxel—ovarian cancer	0.000391	0.000441	CcSEcCtD
Esomeprazole—Constipation—Docetaxel—ovarian cancer	0.000391	0.000441	CcSEcCtD
Esomeprazole—Chills—Epirubicin—ovarian cancer	0.00039	0.000439	CcSEcCtD
Esomeprazole—Visual impairment—Doxorubicin—ovarian cancer	0.000387	0.000436	CcSEcCtD
Esomeprazole—Asthenia—Paclitaxel—ovarian cancer	0.000387	0.000436	CcSEcCtD
Esomeprazole—Alopecia—Epirubicin—ovarian cancer	0.000384	0.000432	CcSEcCtD
Esomeprazole—Pruritus—Paclitaxel—ovarian cancer	0.000382	0.00043	CcSEcCtD
Esomeprazole—Mental disorder—Epirubicin—ovarian cancer	0.00038	0.000429	CcSEcCtD
Esomeprazole—Erythema multiforme—Doxorubicin—ovarian cancer	0.00038	0.000428	CcSEcCtD
Esomeprazole—Malnutrition—Epirubicin—ovarian cancer	0.000378	0.000426	CcSEcCtD
Esomeprazole—Feeling abnormal—Docetaxel—ovarian cancer	0.000377	0.000425	CcSEcCtD
Esomeprazole—Eye disorder—Doxorubicin—ovarian cancer	0.000375	0.000423	CcSEcCtD
Esomeprazole—Tinnitus—Doxorubicin—ovarian cancer	0.000375	0.000422	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000374	0.000422	CcSEcCtD
Esomeprazole—Flushing—Doxorubicin—ovarian cancer	0.000373	0.00042	CcSEcCtD
Esomeprazole—Flatulence—Epirubicin—ovarian cancer	0.000372	0.00042	CcSEcCtD
Esomeprazole—Tension—Epirubicin—ovarian cancer	0.000371	0.000418	CcSEcCtD
Esomeprazole—Dysgeusia—Epirubicin—ovarian cancer	0.00037	0.000417	CcSEcCtD
Esomeprazole—Diarrhoea—Paclitaxel—ovarian cancer	0.000369	0.000416	CcSEcCtD
Esomeprazole—Nervousness—Epirubicin—ovarian cancer	0.000367	0.000414	CcSEcCtD
Esomeprazole—Back pain—Epirubicin—ovarian cancer	0.000366	0.000412	CcSEcCtD
Esomeprazole—Muscle spasms—Epirubicin—ovarian cancer	0.000363	0.00041	CcSEcCtD
Esomeprazole—Immune system disorder—Doxorubicin—ovarian cancer	0.000363	0.000409	CcSEcCtD
Esomeprazole—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000362	0.000408	CcSEcCtD
Esomeprazole—Body temperature increased—Docetaxel—ovarian cancer	0.000362	0.000408	CcSEcCtD
Esomeprazole—Abdominal pain—Docetaxel—ovarian cancer	0.000362	0.000408	CcSEcCtD
Esomeprazole—Chills—Doxorubicin—ovarian cancer	0.00036	0.000406	CcSEcCtD
Esomeprazole—Dizziness—Paclitaxel—ovarian cancer	0.000357	0.000402	CcSEcCtD
Esomeprazole—Vision blurred—Epirubicin—ovarian cancer	0.000356	0.000402	CcSEcCtD
Esomeprazole—Alopecia—Doxorubicin—ovarian cancer	0.000355	0.0004	CcSEcCtD
Esomeprazole—Mental disorder—Doxorubicin—ovarian cancer	0.000352	0.000397	CcSEcCtD
Esomeprazole—Ill-defined disorder—Epirubicin—ovarian cancer	0.000351	0.000395	CcSEcCtD
Esomeprazole—Malnutrition—Doxorubicin—ovarian cancer	0.00035	0.000394	CcSEcCtD
Esomeprazole—Anaemia—Epirubicin—ovarian cancer	0.000349	0.000394	CcSEcCtD
Esomeprazole—Agitation—Epirubicin—ovarian cancer	0.000347	0.000392	CcSEcCtD
Esomeprazole—Flatulence—Doxorubicin—ovarian cancer	0.000345	0.000388	CcSEcCtD
Esomeprazole—Tension—Doxorubicin—ovarian cancer	0.000343	0.000387	CcSEcCtD
Esomeprazole—Vomiting—Paclitaxel—ovarian cancer	0.000343	0.000387	CcSEcCtD
Esomeprazole—Dysgeusia—Doxorubicin—ovarian cancer	0.000342	0.000386	CcSEcCtD
Esomeprazole—Malaise—Epirubicin—ovarian cancer	0.000341	0.000384	CcSEcCtD
Esomeprazole—Rash—Paclitaxel—ovarian cancer	0.00034	0.000383	CcSEcCtD
Esomeprazole—Dermatitis—Paclitaxel—ovarian cancer	0.00034	0.000383	CcSEcCtD
Esomeprazole—Nervousness—Doxorubicin—ovarian cancer	0.00034	0.000383	CcSEcCtD
Esomeprazole—Vertigo—Epirubicin—ovarian cancer	0.00034	0.000383	CcSEcCtD
Esomeprazole—Leukopenia—Epirubicin—ovarian cancer	0.000338	0.000381	CcSEcCtD
Esomeprazole—Back pain—Doxorubicin—ovarian cancer	0.000338	0.000381	CcSEcCtD
Esomeprazole—Headache—Paclitaxel—ovarian cancer	0.000338	0.000381	CcSEcCtD
Esomeprazole—Hypersensitivity—Docetaxel—ovarian cancer	0.000337	0.00038	CcSEcCtD
Esomeprazole—Muscle spasms—Doxorubicin—ovarian cancer	0.000336	0.000379	CcSEcCtD
Esomeprazole—Palpitations—Epirubicin—ovarian cancer	0.000334	0.000376	CcSEcCtD
Esomeprazole—Cough—Epirubicin—ovarian cancer	0.00033	0.000372	CcSEcCtD
Esomeprazole—Vision blurred—Doxorubicin—ovarian cancer	0.00033	0.000372	CcSEcCtD
Esomeprazole—Asthenia—Docetaxel—ovarian cancer	0.000328	0.00037	CcSEcCtD
Esomeprazole—Hypertension—Epirubicin—ovarian cancer	0.000326	0.000368	CcSEcCtD
Esomeprazole—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000324	0.000366	CcSEcCtD
Esomeprazole—Pruritus—Docetaxel—ovarian cancer	0.000324	0.000365	CcSEcCtD
Esomeprazole—Anaemia—Doxorubicin—ovarian cancer	0.000323	0.000364	CcSEcCtD
Esomeprazole—Chest pain—Epirubicin—ovarian cancer	0.000322	0.000363	CcSEcCtD
Esomeprazole—Arthralgia—Epirubicin—ovarian cancer	0.000322	0.000363	CcSEcCtD
Esomeprazole—Myalgia—Epirubicin—ovarian cancer	0.000322	0.000363	CcSEcCtD
Esomeprazole—Agitation—Doxorubicin—ovarian cancer	0.000321	0.000362	CcSEcCtD
Esomeprazole—Anxiety—Epirubicin—ovarian cancer	0.000321	0.000361	CcSEcCtD
Esomeprazole—Nausea—Paclitaxel—ovarian cancer	0.00032	0.000361	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00032	0.00036	CcSEcCtD
Esomeprazole—Discomfort—Epirubicin—ovarian cancer	0.000318	0.000358	CcSEcCtD
Esomeprazole—Malaise—Doxorubicin—ovarian cancer	0.000315	0.000355	CcSEcCtD
Esomeprazole—Dry mouth—Epirubicin—ovarian cancer	0.000315	0.000355	CcSEcCtD
Esomeprazole—Vertigo—Doxorubicin—ovarian cancer	0.000314	0.000354	CcSEcCtD
Esomeprazole—Leukopenia—Doxorubicin—ovarian cancer	0.000313	0.000353	CcSEcCtD
Esomeprazole—Diarrhoea—Docetaxel—ovarian cancer	0.000313	0.000353	CcSEcCtD
Esomeprazole—Confusional state—Epirubicin—ovarian cancer	0.000311	0.000351	CcSEcCtD
Esomeprazole—Palpitations—Doxorubicin—ovarian cancer	0.000309	0.000348	CcSEcCtD
Esomeprazole—Anaphylactic shock—Epirubicin—ovarian cancer	0.000308	0.000348	CcSEcCtD
Esomeprazole—Infection—Epirubicin—ovarian cancer	0.000306	0.000345	CcSEcCtD
Esomeprazole—Cough—Doxorubicin—ovarian cancer	0.000305	0.000344	CcSEcCtD
Esomeprazole—Shock—Epirubicin—ovarian cancer	0.000303	0.000342	CcSEcCtD
Esomeprazole—Nervous system disorder—Epirubicin—ovarian cancer	0.000303	0.000341	CcSEcCtD
Esomeprazole—Dizziness—Docetaxel—ovarian cancer	0.000302	0.000341	CcSEcCtD
Esomeprazole—Thrombocytopenia—Epirubicin—ovarian cancer	0.000302	0.00034	CcSEcCtD
Esomeprazole—Hypertension—Doxorubicin—ovarian cancer	0.000302	0.00034	CcSEcCtD
Esomeprazole—Tachycardia—Epirubicin—ovarian cancer	0.000301	0.000339	CcSEcCtD
Esomeprazole—Skin disorder—Epirubicin—ovarian cancer	0.0003	0.000338	CcSEcCtD
Esomeprazole—Hyperhidrosis—Epirubicin—ovarian cancer	0.000298	0.000336	CcSEcCtD
Esomeprazole—Myalgia—Doxorubicin—ovarian cancer	0.000298	0.000336	CcSEcCtD
Esomeprazole—Chest pain—Doxorubicin—ovarian cancer	0.000298	0.000336	CcSEcCtD
Esomeprazole—Arthralgia—Doxorubicin—ovarian cancer	0.000298	0.000336	CcSEcCtD
Esomeprazole—Anxiety—Doxorubicin—ovarian cancer	0.000297	0.000334	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000296	0.000333	CcSEcCtD
Esomeprazole—Discomfort—Doxorubicin—ovarian cancer	0.000294	0.000332	CcSEcCtD
Esomeprazole—Anorexia—Epirubicin—ovarian cancer	0.000294	0.000331	CcSEcCtD
Esomeprazole—Dry mouth—Doxorubicin—ovarian cancer	0.000291	0.000328	CcSEcCtD
Esomeprazole—Vomiting—Docetaxel—ovarian cancer	0.000291	0.000328	CcSEcCtD
Esomeprazole—Rash—Docetaxel—ovarian cancer	0.000288	0.000325	CcSEcCtD
Esomeprazole—Dermatitis—Docetaxel—ovarian cancer	0.000288	0.000325	CcSEcCtD
Esomeprazole—Confusional state—Doxorubicin—ovarian cancer	0.000288	0.000324	CcSEcCtD
Esomeprazole—Headache—Docetaxel—ovarian cancer	0.000287	0.000323	CcSEcCtD
Esomeprazole—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000285	0.000322	CcSEcCtD
Esomeprazole—Infection—Doxorubicin—ovarian cancer	0.000284	0.00032	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000281	0.000317	CcSEcCtD
Esomeprazole—Shock—Doxorubicin—ovarian cancer	0.000281	0.000317	CcSEcCtD
Esomeprazole—Nervous system disorder—Doxorubicin—ovarian cancer	0.00028	0.000316	CcSEcCtD
Esomeprazole—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000279	0.000315	CcSEcCtD
Esomeprazole—Insomnia—Epirubicin—ovarian cancer	0.000279	0.000314	CcSEcCtD
Esomeprazole—Tachycardia—Doxorubicin—ovarian cancer	0.000279	0.000314	CcSEcCtD
Esomeprazole—Skin disorder—Doxorubicin—ovarian cancer	0.000277	0.000312	CcSEcCtD
Esomeprazole—Paraesthesia—Epirubicin—ovarian cancer	0.000277	0.000312	CcSEcCtD
Esomeprazole—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000276	0.000311	CcSEcCtD
Esomeprazole—Dyspnoea—Epirubicin—ovarian cancer	0.000275	0.00031	CcSEcCtD
Esomeprazole—Somnolence—Epirubicin—ovarian cancer	0.000274	0.000309	CcSEcCtD
Esomeprazole—Anorexia—Doxorubicin—ovarian cancer	0.000272	0.000307	CcSEcCtD
Esomeprazole—Nausea—Docetaxel—ovarian cancer	0.000272	0.000306	CcSEcCtD
Esomeprazole—Dyspepsia—Epirubicin—ovarian cancer	0.000272	0.000306	CcSEcCtD
Esomeprazole—Decreased appetite—Epirubicin—ovarian cancer	0.000268	0.000302	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000266	0.0003	CcSEcCtD
Esomeprazole—Fatigue—Epirubicin—ovarian cancer	0.000266	0.0003	CcSEcCtD
Esomeprazole—Pain—Epirubicin—ovarian cancer	0.000264	0.000297	CcSEcCtD
Esomeprazole—Constipation—Epirubicin—ovarian cancer	0.000264	0.000297	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00026	0.000293	CcSEcCtD
Esomeprazole—Insomnia—Doxorubicin—ovarian cancer	0.000258	0.000291	CcSEcCtD
Esomeprazole—Paraesthesia—Doxorubicin—ovarian cancer	0.000256	0.000289	CcSEcCtD
Esomeprazole—Dyspnoea—Doxorubicin—ovarian cancer	0.000254	0.000287	CcSEcCtD
Esomeprazole—Feeling abnormal—Epirubicin—ovarian cancer	0.000254	0.000287	CcSEcCtD
Esomeprazole—Somnolence—Doxorubicin—ovarian cancer	0.000254	0.000286	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000252	0.000284	CcSEcCtD
Esomeprazole—Dyspepsia—Doxorubicin—ovarian cancer	0.000251	0.000283	CcSEcCtD
Esomeprazole—Decreased appetite—Doxorubicin—ovarian cancer	0.000248	0.00028	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000246	0.000278	CcSEcCtD
Esomeprazole—Fatigue—Doxorubicin—ovarian cancer	0.000246	0.000277	CcSEcCtD
Esomeprazole—Urticaria—Epirubicin—ovarian cancer	0.000245	0.000276	CcSEcCtD
Esomeprazole—Pain—Doxorubicin—ovarian cancer	0.000244	0.000275	CcSEcCtD
Esomeprazole—Constipation—Doxorubicin—ovarian cancer	0.000244	0.000275	CcSEcCtD
Esomeprazole—Body temperature increased—Epirubicin—ovarian cancer	0.000244	0.000275	CcSEcCtD
Esomeprazole—Abdominal pain—Epirubicin—ovarian cancer	0.000244	0.000275	CcSEcCtD
Esomeprazole—Feeling abnormal—Doxorubicin—ovarian cancer	0.000235	0.000265	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000233	0.000263	CcSEcCtD
Esomeprazole—Hypersensitivity—Epirubicin—ovarian cancer	0.000227	0.000256	CcSEcCtD
Esomeprazole—Urticaria—Doxorubicin—ovarian cancer	0.000227	0.000256	CcSEcCtD
Esomeprazole—Abdominal pain—Doxorubicin—ovarian cancer	0.000226	0.000254	CcSEcCtD
Esomeprazole—Body temperature increased—Doxorubicin—ovarian cancer	0.000226	0.000254	CcSEcCtD
Esomeprazole—Asthenia—Epirubicin—ovarian cancer	0.000221	0.000249	CcSEcCtD
Esomeprazole—Pruritus—Epirubicin—ovarian cancer	0.000218	0.000246	CcSEcCtD
Esomeprazole—Diarrhoea—Epirubicin—ovarian cancer	0.000211	0.000238	CcSEcCtD
Esomeprazole—Hypersensitivity—Doxorubicin—ovarian cancer	0.00021	0.000237	CcSEcCtD
Esomeprazole—Asthenia—Doxorubicin—ovarian cancer	0.000205	0.000231	CcSEcCtD
Esomeprazole—Dizziness—Epirubicin—ovarian cancer	0.000204	0.00023	CcSEcCtD
Esomeprazole—Pruritus—Doxorubicin—ovarian cancer	0.000202	0.000228	CcSEcCtD
Esomeprazole—Vomiting—Epirubicin—ovarian cancer	0.000196	0.000221	CcSEcCtD
Esomeprazole—Diarrhoea—Doxorubicin—ovarian cancer	0.000195	0.00022	CcSEcCtD
Esomeprazole—Rash—Epirubicin—ovarian cancer	0.000194	0.000219	CcSEcCtD
Esomeprazole—Dermatitis—Epirubicin—ovarian cancer	0.000194	0.000219	CcSEcCtD
Esomeprazole—Headache—Epirubicin—ovarian cancer	0.000193	0.000218	CcSEcCtD
Esomeprazole—Dizziness—Doxorubicin—ovarian cancer	0.000189	0.000213	CcSEcCtD
Esomeprazole—Nausea—Epirubicin—ovarian cancer	0.000183	0.000207	CcSEcCtD
Esomeprazole—Vomiting—Doxorubicin—ovarian cancer	0.000181	0.000205	CcSEcCtD
Esomeprazole—Rash—Doxorubicin—ovarian cancer	0.00018	0.000203	CcSEcCtD
Esomeprazole—Dermatitis—Doxorubicin—ovarian cancer	0.00018	0.000203	CcSEcCtD
Esomeprazole—Headache—Doxorubicin—ovarian cancer	0.000179	0.000202	CcSEcCtD
Esomeprazole—Nausea—Doxorubicin—ovarian cancer	0.00017	0.000191	CcSEcCtD
